ICD-10-PCS XW1 New Technology: Anatomical Regions Transfusion (original) (raw)

The ICD-10-PCS root operation Transfusion (code XW1) under the New Technology section involves the administration of blood products or cellular therapies into a blood vessel. This operation specifically covers the transfer of therapeutic substances to support or replace blood components or immune functions.

This ICD-10-PCS Transfusion operation is performed via a Percutaneous Approach into either a Peripheral Vein or Central Vein. The detailed codes represent transfusions of advanced therapies such as Convalescent Plasma (Nonautologous), Marnetegragene Autotemcel, and various immune globulins, highlighting the procedure’s use in innovative treatments. For example, code XW13325 describes a transfusion of convalescent plasma into a peripheral vein, while XW1437A refers to transfusion of Marnetegragene Autotemcel into a central vein. These codes denote the precision in coding modern transfusion techniques within the anatomical regions category, facilitating accurate procedural documentation for novel therapies.

List of ICD-10-PCS codes used to specify XW1 - Transfusion (putting in blood or blood products). There are a total of 25 procedure codes in this section.

• XW1 - New Technology, Anatomical Regions, Transfusion
• XW13325 - Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
• XW1337A - Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW133B8 - Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
• XW133C8 - Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
• XW133D7 - Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
• XW133E7 - Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
• XW133F8 - Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
• XW133G8 - Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
• XW133H9 - Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
• XW133J8 - Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
• XW133SB - Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW133YB - Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, N...
• XW14325 - Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5
• XW1437A - Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10
• XW143B8 - Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
• XW143C8 - Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8
• XW143D7 - Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
• XW143E7 - Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
• XW143F8 - Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
• XW143G8 - Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
• XW143H9 - Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
• XW143J8 - Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
• XW143SB - Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11
• XW143YB - Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New ...